Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence (Q36638826)

15 August 2017

Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence (English)

1 reference

multidrug-resistant tuberculosis

15 August 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

Molly F Franke

1

0 references

Jennifer Furin

4

object named as

Jennifer J Furin

1 reference

15 August 2017

9

Mercedes C Becerra

1 reference

15 August 2017

Sasha C Appleton

2

1 reference

15 August 2017

Carole D Mitnick

3

1 reference

15 August 2017

Jaime Bayona

5

1 reference

15 August 2017

Katiuska Chalco

6

1 reference

15 August 2017

Sonya Shin

7

1 reference

15 August 2017

Megan Murray

8

1 reference

15 August 2017

language of work or name

English

0 references

publication date

7 December 2012

1 reference

Clinical Infectious Diseases

15 August 2017

1 reference

15 August 2017

56

1 reference

15 August 2017

6

1 reference

15 August 2017

770-776

1 reference

Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Recurrence after successful treatment among patients with multidrug-resistant tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Factors associated with anti-tuberculosis medication adverse effects: a case-control study in Lima, Peru

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

The impact of diabetes on tuberculosis treatment outcomes: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Follow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Development of extensively drug-resistant tuberculosis during multidrug-resistant tuberculosis treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Risk factors for MDR and XDR-TB in a tertiary referral hospital in India

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Type 2 diabetes and multidrug-resistant tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Nurses as providers of emotional support to patients with MDR-TB.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Treatment of multidrug-resistant tuberculosis: evidence and controversies.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Programmes and principles in treatment of multidrug-resistant tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Informatics tools to monitor progress and outcomes of patients with drug resistant tuberculosis in Peru

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Totally drug-resistant tuberculosis in India.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

The treatment of multidrug-resistant tuberculosis in Turkey

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3582355

Recurrence after Treatment for Pulmonary Multidrug‐Resistant Tuberculosis

4 December 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FCID%2FCIS1008

Hyperglycaemia and absorption of sulphonylurea drugs

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23223591

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23223591

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/CID/CIS1008

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23223591

1 reference